Table I Index
Table of Contents
|
Table I - 41 Johnson Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 366 | 347.2 | 166 | 374.2 | 200 | 336.7 |
| Oral cavity and pharynx | 9 | 9.2** | 5 | 11.2** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 48 | 45.9 | 23 | 53.8 | 25 | 41.5 |
| Esophagus | 5 | 5.1** | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 18 | 16.1** | 6 | 13.3** | 12 | 19.2** |
| Rectum and rectosigmoid | 11 | 9.9** | * | # | 7 | 10.8** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 5 | 4.9** | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 69 | 69.8 | 48 | 111.5 | 21 | 37.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 67 | 68.3 | 46 | 107.7 | 21 | 37.4 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 10 | 8.4** | * | # | 6 | 9.1** |
| Melanoma of the skin | 10 | 8.4** | * | # | 6 | 9.1** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 88 | 76.9 | * | # | 87 | 140.6 |
| Female genital system | 25 | 24.2 | -- | -- | 25 | 45.7 |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 15 | 14.5** | -- | -- | 15 | 27.5** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 8 | 8.0** | -- | -- | 8 | 14.9** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 38 | 39.1 | 38 | 86.9 | -- | -- |
| Prostate gland | 37 | 38.3 | 37 | 85.4 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 29 | 27.5 | 20 | 43.6 | 9 | 16.1** |
| Urinary bladder | 15 | 13.9** | 9 | 20.3** | 6 | 10.0** |
| Kidney and renal pelvis | 14 | 13.6** | 11 | 23.3** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | * | # | * | # | * | # |
| Brain | * | # | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 6 | 5.1** | * | # | * | # |
| Thyroid gland | 6 | 5.1** | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 12 | 11.5** | 7 | 14.9** | 5 | 7.7** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 9 | 8.2** | 5 | 10.5** | * | # |
| Multiple myeloma | 7 | 6.7** | * | # | * | # |
| Leukemia | * | # | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 14 | 11.7** | 7 | 14.5** | 7 | 9.8** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||